GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » COGS-to-Revenue

Central Pharmaceutical JSC No2 (HSTC:DP2) COGS-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 COGS-to-Revenue?

Central Pharmaceutical JSC No2's Cost of Goods Sold for the six months ended in . 20 was ₫0.00 Mil. Its Revenue for the six months ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Central Pharmaceutical JSC No2's Gross Margin % for the six months ended in . 20 was N/A%.


Central Pharmaceutical JSC No2 COGS-to-Revenue Historical Data

The historical data trend for Central Pharmaceutical JSC No2's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 COGS-to-Revenue Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
COGS-to-Revenue

Central Pharmaceutical JSC No2 Semi-Annual Data
COGS-to-Revenue

Central Pharmaceutical JSC No2 COGS-to-Revenue Calculation

Central Pharmaceutical JSC No2's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

Central Pharmaceutical JSC No2's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceutical JSC No2  (HSTC:DP2) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Central Pharmaceutical JSC No2's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Central Pharmaceutical JSC No2 COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines